117 related articles for article (PubMed ID: 2311446)
21. Nafcillin entry into human cerebrospinal fluid.
Fossieck BE; Kane JG; Diaz CR; Parker RH
Antimicrob Agents Chemother; 1977 Jun; 11(6):965-7. PubMed ID: 879761
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative ultrasound guidance for the placement of permanent ventricular cerebrospinal fluid shunt catheters: a single-center historical cohort study.
Crowley RW; Dumont AS; Asthagiri AR; Torner JC; Medel R; Jane JA; Jane JA; Kassell NF
World Neurosurg; 2014 Feb; 81(2):397-403. PubMed ID: 23321382
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
Kearns CM; Blakley RL; Santana VM; Crom WR
Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of nafcillin in infants with low birth weights.
Banner W; Gooch WM; Burckart G; Korones SB
Antimicrob Agents Chemother; 1980 Apr; 17(4):691-4. PubMed ID: 7396459
[TBL] [Abstract][Full Text] [Related]
25. The gravity-assisted Paedi-Gav valve in the treatment of pediatric hydrocephalus.
Meling TR; Egge A; Due-Tønnessen B
Pediatr Neurosurg; 2005; 41(1):8-14. PubMed ID: 15886507
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the risk of shunt failure or infection related to cerebrospinal fluid cell count, protein level, and glucose levels in low-birth-weight premature infants with posthemorrhagic hydrocephalus.
Fulkerson DH; Vachhrajani S; Bohnstedt BN; Patel NB; Patel AJ; Fox BD; Jea A; Boaz JC
J Neurosurg Pediatr; 2011 Feb; 7(2):147-51. PubMed ID: 21284459
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of nafcillin in patients with renal failure.
Diaz CR; Kane JG; Parker RH; Pelsor FR
Antimicrob Agents Chemother; 1977 Jul; 12(1):98-101. PubMed ID: 883823
[TBL] [Abstract][Full Text] [Related]
28. Clinical and pharmacokinetic evaluation of nafcillin in infants and children.
Feldman WE; Nelson JD; Stanberry LR
J Pediatr; 1978 Dec; 93(6):1029-33. PubMed ID: 722420
[TBL] [Abstract][Full Text] [Related]
29. A multicenter study of factors influencing cerebrospinal fluid shunt survival in infants and children.
Shah SS; Hall M; Slonim AD; Hornig GW; Berry JG; Sharma V
Neurosurgery; 2008 May; 62(5):1095-102; discussion 1102-3. PubMed ID: 18580807
[TBL] [Abstract][Full Text] [Related]
30. Functioning periods and complications of 246 cerebrospinal fluid shunting procedures in 208 children.
Lee JY; Wang KC; Cho BK
J Korean Med Sci; 1995 Aug; 10(4):275-80. PubMed ID: 8593208
[TBL] [Abstract][Full Text] [Related]
31. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial.
Rozzelle CJ; Leonardo J; Li V
J Neurosurg Pediatr; 2008 Aug; 2(2):111-7. PubMed ID: 18671615
[TBL] [Abstract][Full Text] [Related]
33. [The cerebrospinal fluid shunt].
Puget S
Arch Pediatr; 2005 Feb; 12(2):224-7. PubMed ID: 15694555
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus.
Cengiz P; Zemlan F; Ellenbogen R; Hawkins D; Zimmerman JJ
Pediatr Crit Care Med; 2008 Sep; 9(5):524-9. PubMed ID: 18679140
[TBL] [Abstract][Full Text] [Related]
35. Evidence of an interaction between nifedipine and nafcillin in humans.
Lang CC; Jamal SK; Mohamed Z; Mustafa MR; Mustafa AM; Lee TC
Br J Clin Pharmacol; 2003 Jun; 55(6):588-90. PubMed ID: 12814453
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus.
Tuli S; Drake J; Lawless J; Wigg M; Lamberti-Pasculli M
J Neurosurg; 2000 Jan; 92(1):31-8. PubMed ID: 10616079
[TBL] [Abstract][Full Text] [Related]
37. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
38. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
Gruber RW; Roehrig B
J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid shunt infection: a prospective study of risk factors.
Kulkarni AV; Drake JM; Lamberti-Pasculli M
J Neurosurg; 2001 Feb; 94(2):195-201. PubMed ID: 11213954
[TBL] [Abstract][Full Text] [Related]
40. Predictors of death in pediatric patients requiring cerebrospinal fluid shunts.
Tuli S; Tuli J; Drake J; Spears J
J Neurosurg; 2004 May; 100(5 Suppl Pediatrics):442-6. PubMed ID: 15287452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
